Oikawa Y - Search Results

1

Clinical Significance of Insulin Peptide-specific Interferon-γ-related Immune Responses in Ketosis-prone Type 2 Diabetes.

Satomura A, Oikawa Y, Haisa A, Suzuki S, Nakanishi S, Katsuki T, Shimada A. Satomura A, et al. Among authors: oikawa y. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2124-e2132. doi: 10.1210/clinem/dgab912. J Clin Endocrinol Metab. 2022. PMID: 34922394

2

Elevated serum IP-10 levels observed in type 1 diabetes.

Shimada A, Morimoto J, Kodama K, Suzuki R, Oikawa Y, Funae O, Kasuga A, Saruta T, Narumi S. Shimada A, et al. Among authors: oikawa y. Diabetes Care. 2001 Mar;24(3):510-5. doi: 10.2337/diacare.24.3.510. Diabetes Care. 2001. PMID: 11289477

3

T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes.

Shimada A, Morimoto J, Kodama K, Oikawa Y, Irie J, Nakagawa Y, Narumi S, Saruta T. Shimada A, et al. Among authors: oikawa y. Diabetes Care. 2002 Mar;25(3):635-6. doi: 10.2337/diacare.25.3.635. Diabetes Care. 2002. PMID: 11874969 No abstract available.

4

A case of fulminant type 1 diabetes with strong evidence of autoimmunity.

Shimada A, Oikawa Y, Shigihara T, Senda T, Kodama K. Shimada A, et al. Among authors: oikawa y. Diabetes Care. 2002 Aug;25(8):1482-3. doi: 10.2337/diacare.25.8.1482. Diabetes Care. 2002. PMID: 12145259 No abstract available.

5

High frequency of valpha24(+) vbeta11(+) T-cells observed in type 1 diabetes.

Oikawa Y, Shimada A, Yamada S, Motohashi Y, Nakagawa Y, Irie J, Maruyama T, Saruta T. Oikawa Y, et al. Diabetes Care. 2002 Oct;25(10):1818-23. doi: 10.2337/diacare.25.10.1818. Diabetes Care. 2002. PMID: 12351484

6

T-cell function in anti-GAD65(+)diabetes with residual beta-cell function.

Suzuki R, Shimada A, Maruyama T, Funae O, Morimoto J, Kodama K, Oikawa Y, Kasuga A, Matsubara K, Saruta T, Narumi S. Suzuki R, et al. Among authors: oikawa y. J Autoimmun. 2003 Feb;20(1):83-90. doi: 10.1016/s0896-8411(02)00093-8. J Autoimmun. 2003. PMID: 12604315

7

Assessment of beta cell mass and oxidative peritoneal exudate cells in murine type 1 diabetes using adoptive transfer system.

Yamada S, Irie J, Shimada A, Kodama K, Morimoto J, Suzuki R, Oikawa Y, Saruta T. Yamada S, et al. Among authors: oikawa y. Autoimmunity. 2003 Mar;36(2):63-70. doi: 10.1080/0891693031000079266. Autoimmunity. 2003. PMID: 12820687 Free article.

8

Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice.

Oikawa Y, Shimada A, Kasuga A, Morimoto J, Osaki T, Tahara H, Miyazaki T, Tashiro F, Yamato E, Miyazaki J, Saruta T. Oikawa Y, et al. J Immunol. 2003 Dec 1;171(11):5865-75. doi: 10.4049/jimmunol.171.11.5865. J Immunol. 2003. PMID: 14634096

9

Relationship between beta cell mass of NOD donors and diabetes development of NOD-scid recipients in adoptive transfer system.

Yamada S, Shimada A, Kodama K, Morimoto J, Suzuki R, Oikawa Y, Irie J, Saruta T. Yamada S, et al. Among authors: oikawa y. Ann N Y Acad Sci. 2003 Nov;1005:211-4. doi: 10.1196/annals.1288.028. Ann N Y Acad Sci. 2003. PMID: 14679061

10

NKT cell frequency in Japanese type 1 diabetes.

Oikawa Y, Shimada A, Yamada S, Motohashi Y, Nakagawa Y, Irie J, Maruyama T, Saruta T. Oikawa Y, et al. Ann N Y Acad Sci. 2003 Nov;1005:230-2. doi: 10.1196/annals.1288.033. Ann N Y Acad Sci. 2003. PMID: 14679066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters